CompletedPhase 2NCT04836273
Treatment of Post-bariatric Hypoglycaemia
Studying Congenital isolated hyperinsulinism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Filip Krag Knop
- Principal Investigator
- Filip K Knop, MD, PhDCenter for Clinical Metabolic Research at Gentofte Hospital
- Intervention
- Dasiglucagon(drug)
- Enrollment
- 24 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2021 – 2022
Study locations (1)
- Center for Clinical Metabolic Research, Herlev-Gentofte Hospital, Hellerup, Denmark
Collaborators
Zealand Pharma
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04836273 on ClinicalTrials.gov